Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Part of paid clinical trials in Huntsville, Alabama.
- Sponsor
- AstraZeneca
- Study ID
- NCT01563978
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- fostamatinib — DRUGfostamatinib 100 mg twice daily
- placebo — DRUGplacebo
Study Details
The purpose of this study is to evaluate the effect of fostamatinib compared to placebo on ambulatory blood pressure in patients with active rheumatoid arthritis who are taking a disease-modifying anti-rheumatic drug (DMARD). The study will last for 57 days.
Key Dates
- Start date
- Apr 30, 2012
- Status verified
- Apr 2014
- Primary completion
- Jan 31, 2013
- Completion
- Jan 31, 2013
Study Design
- Enrollment
- 266 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Dosing Regimen AOral treatment
- Placebo Comparator: Dosing Regimen BOral treatment
Primary Outcome Measure
Change From Baseline in 24-hour Mean Ambulatory SBP [ Time Frame: 4 weeks ]
Locations (30)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | - | - |
| Research Site | Huntington Beach | California | - | - |
| Research Site | Santa Maria | California | - | - |
| Research Site | Trumbull | Connecticut | - | - |
| Research Site | Boca Raton | Florida | - | - |
| Research Site | Brandon | Florida | - | - |
| Research Site | Orlando | Florida | - | - |
| Research Site | Tampa | Florida | - | - |
| Research Site | Venice | Florida | - | - |
| Research Site | Decatur | Georgia | - | - |
| Research Site | South Bend | Indiana | - | - |
| Research Site | Cumberland | Maryland | - | - |
| Research Site | Frederick | Maryland | - | - |
| Research Site | Hagerstown | Maryland | - | - |
| Research Site | Florissant | Missouri | - | - |
| Research Site | Richmond Heights | Missouri | - | - |
| Research Site | Freehold | New Jersey | - | - |
| Research Site | Albuquerque | New Mexico | - | - |
| Research Site | Brooklyn | New York | - | - |
| Research Site | Charlotte | North Carolina | - | - |
| Research Site | Greensboro | North Carolina | - | - |
| Research Site | Lake Oswego | Oregon | - | - |
| Research Site | Duncansville | Pennsylvania | - | - |
| Research Site | Memphis | Tennessee | - | - |
| Research Site | Austin | Texas | - | - |
| Research Site | Dallas | Texas | - | - |
| Research Site | Houston | Texas | - | - |
| Research Site | Lubbock | Texas | - | - |
| Research Site | Nassau Bay | Texas | - | - |
| Research Site | Tacoma | Washington | - | - |
Find similar trials in Huntsville, AL
By condition
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut